SEOM卵巢癌临床指南 2020

2021-02-01 西班牙医学肿瘤学会( Spanish Society of Medical Oncology) Clin Transl Oncol. 2021 Jan 30.

尽管在分子生物学和治疗方面的知识取得了显着进步,但卵巢癌仍然是妇科癌症死亡的主要原因。 在过去的十年中,全身治疗和外科治疗均取得了重要进展。 然而,毫无疑问的是,PARP抑制剂作为铂类化学疗法的反应后

中文标题:

SEOM卵巢癌临床指南 2020

英文标题:

SEOM clinical guideline in ovarian cancer (2020).

发布日期:

2021-02-01

简要介绍:

尽管在分子生物学和治疗方面的知识取得了显着进步,但卵巢癌仍然是妇科癌症死亡的主要原因。 在过去的十年中,全身治疗和外科治疗均取得了重要进展。 然而,毫无疑问的是,PARP抑制剂作为铂类化学疗法的反应后的维持剂,即复发性疾病中的frst以及最近也存在于frst品系中,将改变该疾病的自然病史。 本指南的目的是总结有关卵巢癌的诊断,治疗和随访的最新证据, 并为临床实践提供循证建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=Ovarian.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4698c1c002055308, title=SEOM卵巢癌临床指南 2020, enTitle= SEOM clinical guideline in ovarian cancer (2020)., guiderFrom=Clin Transl Oncol. 2021 Jan 30., authorId=0, author=, summary=尽管在分子生物学和治疗方面的知识取得了显着进步,但卵巢癌仍然是妇科癌症死亡的主要原因。 在过去的十年中,全身治疗和外科治疗均取得了重要进展。 然而,毫无疑问的是,PARP抑制剂作为铂类化学疗法的反应后, cover=, journalId=0, articlesId=null, associationId=1918, associationName=西班牙医学肿瘤学会( Spanish Society of Medical Oncology), associationIntro= Spanish Society of Medical Oncology, copyright=0, guiderPublishedTime=Mon Feb 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">尽管在分子生物学和治疗方面的知识取得了显着进步,但卵巢癌仍然是妇科癌症死亡的主要原因。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="1">在过去的十年中,全身治疗和外科治疗均取得了重要进展。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="2">然而,毫无疑问的是,PARP抑制剂作为铂类化学疗法的反应后的维持剂,即复发性疾病中的frst以及最近也存在于frst品系中,将改变该疾病的自然病史。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="4">本指南的目的是总结有关卵巢癌的诊断,治疗和随访的最新证据,</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="6">并为临床实践提供循证建议。</span></span></p>, tagList=[TagDto(tagId=359, tagName=卵巢癌)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2343, appHits=336, showAppHits=0, pcHits=558, showPcHits=2007, likes=1, shares=5, comments=10, approvalStatus=1, publishedTime=Sat Feb 13 17:21:22 CST 2021, publishedTimeString=2021-02-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=fbzhang, createdTime=Sat Feb 13 17:20:05 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 02:00:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=Ovarian.pdf)])
Ovarian.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1079868, encodeId=3f8810e986860, content=不错不错,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a66146548, createdName=ms4000001362049660, createdTime=Tue Dec 14 10:21:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070076, encodeId=558310e007621, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:51:31 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069065, encodeId=85221069065b7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:17 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069064, encodeId=155d106906468, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:06 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052254, encodeId=8e471052254d4, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:45 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-12-14 ms4000001362049660

    不错不错,受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1079868, encodeId=3f8810e986860, content=不错不错,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a66146548, createdName=ms4000001362049660, createdTime=Tue Dec 14 10:21:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070076, encodeId=558310e007621, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:51:31 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069065, encodeId=85221069065b7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:17 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069064, encodeId=155d106906468, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:06 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052254, encodeId=8e471052254d4, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:45 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-11-14 陌上咖啡

    谢谢!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1079868, encodeId=3f8810e986860, content=不错不错,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a66146548, createdName=ms4000001362049660, createdTime=Tue Dec 14 10:21:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070076, encodeId=558310e007621, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:51:31 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069065, encodeId=85221069065b7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:17 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069064, encodeId=155d106906468, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:06 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052254, encodeId=8e471052254d4, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:45 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-11-10 123d380fm22暂无昵称

    挺好的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1079868, encodeId=3f8810e986860, content=不错不错,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a66146548, createdName=ms4000001362049660, createdTime=Tue Dec 14 10:21:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070076, encodeId=558310e007621, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:51:31 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069065, encodeId=85221069065b7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:17 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069064, encodeId=155d106906468, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:06 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052254, encodeId=8e471052254d4, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:45 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-11-10 123d380fm22暂无昵称

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1079868, encodeId=3f8810e986860, content=不错不错,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28a66146548, createdName=ms4000001362049660, createdTime=Tue Dec 14 10:21:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070076, encodeId=558310e007621, content=谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:51:31 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069065, encodeId=85221069065b7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:17 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069064, encodeId=155d106906468, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54332440436, createdName=123d380fm22暂无昵称, createdTime=Wed Nov 10 20:18:06 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052254, encodeId=8e471052254d4, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:45 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-09-17 H8888888

    文章不错 谢谢分享

    0